Total Payments
$12,248
2024 Payments
$1,901
Companies
40
Transactions
419
Medicare Patients
4,756
Medicare Billing
$541,336
Payment Breakdown by Category
Food & Beverage$11,187 (91.3%)
Travel$1,053 (8.6%)
Education$7.95 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,187 | 415 | 91.3% |
| Travel and Lodging | $1,053 | 3 | 8.6% |
| Education | $7.95 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $1,583 | 38 | $0 (2024) |
| Abbott Laboratories | $1,256 | 20 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,203 | 64 | $0 (2024) |
| PFIZER INC. | $1,152 | 83 | $0 (2024) |
| Penumbra, Inc. | $1,002 | 3 | $0 (2019) |
| Inari Medical, Inc. | $937.59 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $544.63 | 29 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $510.68 | 18 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $441.42 | 28 | $0 (2023) |
| BIOTRONIK INC. | $438.00 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,901 | 68 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($353.44) |
| 2023 | $2,207 | 63 | Inari Medical, Inc. ($667.16) |
| 2022 | $1,405 | 67 | Novartis Pharmaceuticals Corporation ($230.01) |
| 2021 | $1,585 | 56 | BIOTRONIK INC. ($295.54) |
| 2020 | $894.48 | 50 | PFIZER INC. ($281.13) |
| 2019 | $2,088 | 56 | Penumbra, Inc. ($1,002) |
| 2018 | $1,744 | 39 | Abbott Laboratories ($987.05) |
| 2017 | $424.23 | 20 | Novartis Pharmaceuticals Corporation ($211.35) |
All Payment Transactions
419 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Cardiovascular | ||||||
| 12/04/2024 | ShockWave Medical, Inc | Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) | Food and Beverage | In-kind items and services | $222.94 | General |
| Category: Lithoplasty | ||||||
| 11/21/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.33 | General |
| Category: Cardiology | ||||||
| 11/11/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Genetic Disease | ||||||
| 11/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $128.89 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $8.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/31/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $11.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/17/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.43 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.63 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/03/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.89 | General |
| Category: DIABETES | ||||||
| 09/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $13.28 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/05/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $47.40 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $1.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/29/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $33.67 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: DIABETES | ||||||
| 08/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $22.04 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/26/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $9.23 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/22/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Genetic Disease | ||||||
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | EVKEEZA (Biological) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: CARDIOVASCULAR AND METABOLISM | ||||||
| 08/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $10.16 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/09/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: Genetic Disease | ||||||
| 08/06/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.42 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,424 | 2,037 | $486,001 | $167,100 |
| 2022 | 23 | 1,383 | 2,034 | $451,143 | $158,082 |
| 2021 | 16 | 1,159 | 1,617 | $312,690 | $125,268 |
| 2020 | 16 | 790 | 1,113 | $199,634 | $90,886 |
Total Patients
4,756
Total Services
6,801
Medicare Billing
$541,336
Procedure Codes
79
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 174 | 385 | $96,250 | $37,815 | 39.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 180 | 352 | $55,616 | $34,443 | 61.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 99 | 101 | $70,700 | $17,055 | 24.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 39 | 39 | $42,900 | $15,439 | 36.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 79 | 83 | $22,825 | $11,185 | 49.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 39 | 154 | $16,170 | $7,009 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 92 | $10,304 | $6,516 | 63.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 49 | 49 | $9,825 | $6,214 | 63.2% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 43 | 80 | $64,000 | $6,014 | 9.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 30 | 30 | $24,000 | $5,911 | 24.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 88 | 88 | $21,120 | $5,074 | 24.0% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 51 | 51 | $13,515 | $3,131 | 23.2% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 16 | 16 | $7,280 | $2,815 | 38.7% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 11 | 11 | $4,400 | $2,504 | 56.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 166 | 199 | $9,950 | $2,281 | 22.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 178 | 186 | $3,086 | $1,247 | 40.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Office | 2023 | 19 | 19 | $3,705 | $845.28 | 22.8% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Office | 2023 | 30 | 30 | $6,000 | $646.41 | 10.8% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 24 | 24 | $1,560 | $441.76 | 28.3% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 23 | 23 | $1,035 | $274.62 | 26.5% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 24 | 25 | $1,760 | $238.20 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 156 | 330 | $52,140 | $33,132 | 63.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 139 | 350 | $87,500 | $29,720 | 34.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 35 | 35 | $38,500 | $14,918 | 38.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 78 | 80 | $22,000 | $12,798 | 58.2% |
About Dr. Sarah Elsayed, M.D
Dr. Sarah Elsayed, M.D is a Cardiovascular Disease healthcare provider based in Fountain Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/10/2011. The National Provider Identifier (NPI) number assigned to this provider is 1396049029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Elsayed, M.D has received a total of $12,248 in payments from pharmaceutical and medical device companies, with $1,901 received in 2024. These payments were reported across 419 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($11,187).
As a Medicare-enrolled provider, Elsayed has provided services to 4,756 Medicare beneficiaries, totaling 6,801 services with total Medicare billing of $541,336. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Fountain Valley, CA
- Active Since 01/10/2011
- Last Updated 06/11/2018
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396049029
Products in Payments
- LifeVest (Device) $1,583
- ELIQUIS (Drug) $1,111
- Indigo (Device) $1,002
- FLOWTRIEVER CATHETER, S (Device) $937.59
- AMPLATZER Occluders (Device) $813.84
- ENTRESTO (Drug) $756.78
- XARELTO (Drug) $546.99
- LEQVIO (Drug) $446.56
- JARDIANCE (Drug) $441.09
- CAMZYOS (Drug) $229.76
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $223.93
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter (Device) $222.94
- MULTAQ (Drug) $199.87
- PK Papyrus (Device) $194.34
- FARXIGA (Drug) $184.86
- Confirm Rx (Device) $178.31
- CardioInsight (Device) $150.76
- Assure WCD (Device) $140.94
- LINQ II (Device) $138.72
- VYNDAQEL (Drug) $127.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Fountain Valley
Bao Bui, M.d, M.D
Cardiovascular Disease — Payments: $357,481
Cardiovascular Disease $357,481
Dr. Robert Greenfield, Md, MD
Cardiovascular Disease — Payments: $67,004
Cardiovascular Disease $67,004
Dr. Arvind Nirula, M.d, M.D
Cardiovascular Disease — Payments: $20,973
Cardiovascular Disease $20,973
Dr. Amanda Donohue, D.o, D.O
Cardiovascular Disease — Payments: $6,294
Cardiovascular Disease $6,294
Tuan Nguyen, M.d, M.D
Cardiovascular Disease — Payments: $4,674
Cardiovascular Disease $4,674
Dr. Steven Schiff, Md, Facc, Inc, MD, FACC, INC
Cardiovascular Disease — Payments: $4,122
Cardiovascular Disease $4,122